Today’s top gainers include the company Amgen Inc. (NASDAQ:AMGN) which is in the industry Biotechnology, gaining -0.21% today. In the last week its performance is -1.28%, and 6.60% for the past quarter. Currently, Amgen Inc., AMGN has a target price of 191, so today’s gain of -0.21% is a significant step towards its target price. The GAP today is therefore 0.25%.
Amgen Inc. (NASDAQ:AMGN), has a market cap of 127319.01, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.10%.
At the current price of 169.77, it has a dividend yield of 2.36%, and its target price is 191. This is with a profit margin of 33.10%, and total debt/equity of 1.1. Amgen Inc. (NASDAQ:AMGN) has a P/E of 17.37, as well as a forward P/E of 13.59.
With a current EPS of 9.77, and a forecasted EPS growth for next year at 9.91%,Amgen Inc. (NASDAQ:AMGN) has had a EPS growth for the past five years at 13.60%. For the next five years EPS growth is projected to be 7.93%.
Performance for the year is 16.57%. Since its IPO date on 9/7/1984, the total performance to date is 6.62%.
Volume today for Amgen Inc. (NASDAQ:AMGN), is 2073600, while its average volume is 2878.12. Whilst the total gain today was -0.21%, it did have a day high of -3.89%.
Volatility for this week has been at 1.04%, and 1.39% for the month. The 52-week low for Amgen Inc., AMGN has been 33.72%, while the 52-week-high has reached -3.89%.
Looking at its return of investments, which is 12.50%, and its return on assets is 10.10%. Amgen Inc. (NASDAQ:AMGN) has an operating margin of 40.70%. With a sales growth of 5.90% quarter over quarter. Bearing in mind that Amgen Inc., AMGN is in the sector Healthcare, its long-term debt/equity is 0.93, and has a current ratio of 4 and 3.7 for quick ratio.
So what is the value of Amgen Inc.? Well its PEG is 2.19, and the P/S is 5.67, along with a P/B of 4.23. Meanwhile it has a p/cash of 3.63.